Logo
Apparel & Fashion

Description

Sulphamethoxazole represents a high-purity sulfonamide antibiotic active pharmaceutical ingredient manufactured in FDA-approved facilities with over five decades of pharmaceutical manufacturing expertise. This essential bulk drug is available in multiple pharmacopeial grades including Indian Pharmacopoeia, British Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopeia, ensuring comprehensive compliance with international quality standards for pharmaceutical production. The manufacturing process incorporates rigorous quality control measures and documentation systems that meet global regulatory requirements, providing pharmaceutical partners with a reliable raw material source for anti-infective drug development and production. The consistent quality and purity make this API suitable for both established pharmaceutical formulations and new drug development projects requiring dependable active ingredients.

This antibiotic API finds extensive application across multiple th...
Sulphamethoxazole represents a high-purity sulfonamide antibiotic active pharmaceutical ingredient manufactured in FDA-approved facilities with over five decades of pharmaceutical manufacturing expertise. This essential bulk drug is available in multiple pharmacopeial grades including Indian Pharmacopoeia, British Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopeia, ensuring comprehensive compliance with international quality standards for pharmaceutical production. The manufacturing process incorporates rigorous quality control measures and documentation systems that meet global regulatory requirements, providing pharmaceutical partners with a reliable raw material source for anti-infective drug development and production. The consistent quality and purity make this API suitable for both established pharmaceutical formulations and new drug development projects requiring dependable active ingredients.

This antibiotic API finds extensive application across multiple therapeutic areas within the pharmaceutical industry, primarily serving manufacturers producing combination therapies, especially co-trimoxazole formulations that address a broad spectrum of bacterial infections. Human pharmaceutical manufacturers utilize Sulphamethoxazole for producing tablets, oral suspensions, and injectable formulations targeting urinary tract infections, respiratory tract infections, and gastrointestinal diseases. The veterinary pharmaceutical sector extensively employs this API for manufacturing medications for livestock, poultry, and companion animals, addressing bacterial infections that affect animal health and productivity. Additionally, generic drug manufacturers and compounding pharmacies constitute significant users who value the consistent quality and reliable supply chain for producing affordable antibiotic treatments that serve diverse healthcare markets and patient populations worldwide.

The business value of sourcing Sulphamethoxazole from this established manufacturing partner lies in the exceptional reliability, regulatory compliance, and supply chain stability developed through decades of pharmaceutical manufacturing experience. The FDA-approved manufacturing facility and multiple pharmacopeia certifications ensure that procurement partners receive API that consistently meets the most stringent quality requirements for regulated markets across different regions. Ready stock availability eliminates production delays and ensures manufacturing continuity, while the comprehensive quality assurance systems provide documentation and traceability that support regulatory submissions and quality management systems. This operational reliability translates to reduced supply chain risk, consistent final product quality, and seamless integration into manufacturing processes, ultimately protecting brand reputation and ensuring patient safety through dependable pharmaceutical ingredients.

Key Features:
- Manufactured in FDA-approved facility with comprehensive regulatory compliance
- Available in multiple pharmacopeial grades including IP, BP, EP, and USP
- Ready stock availability ensuring immediate shipment and supply chain reliability
- High purity injectable grade option suitable for parenteral formulations
- Consistent quality backed by decades of pharmaceutical manufacturing expertise

Benefits:
- Regulatory compliance across multiple international markets and standards
- Supply chain reliability with immediate availability reducing production delays
- Consistent quality and purity ensuring predictable manufacturing outcomes
- Versatile application across multiple dosage forms and therapeutic areas
- Established manufacturing track record providing confidence in product quality

Specifications

Additional Information
Country of OriginIndia

Application

Sulphamethoxazole API serves as a fundamental sulfonamide antibiotic active pharmaceutical ingredient extensively used in compounding and manufacturing combination drug therapies. It is most commonly formulated with trimethoprim to create the widely used co-trimoxazole combination, delivering broad-spectrum antibacterial efficacy across multiple dosage forms including tablets, suspensions, and injectable solutions for comprehensive infection treatment protocols. The versatility of this bulk API allows it to meet stringent international pharmacopeia standards including IP, BP, EP, and USP, making it suitable for regulated markets worldwide. Pharmaceutical companies, compounding pharmacies, and veterinary drug manufacturers rely on this consistent, high-purity raw material for producing essential anti-infective medications that are critical to both human healthcare systems and animal health management programs. - Manufacturing co-trimoxazole combination tablets for treating urinary tract infections, bronchitis, and gastrointestinal infections - Formulating oral suspensions for pediatric patients requiring antibiotic therapy for middle ear infections and respiratory conditions - Producing injectable solutions for hospital use in treating severe pneumocystis pneumonia, particularly in immunocompromised patients - Compounding veterinary medications for treating bacterial infections in livestock, poultry, and companion animals - Supplying generic drug manufacturers producing affordable antibiotic formulations for public health programs and essential medicine lists

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

A. S. Joshi & Company, Maharashtra
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler•Importer / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Sulphamethoxazole API Bulk IP BP EP USP Injectable Antibiotic

Premium Sulphamethoxazole API bulk from FDA-approved manufacturer since 1971. Available in IP, BP, EP, USP, and injectable grades for reliable pharmaceutical production and global supply chain partners.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

A. S. Joshi & Company
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler

More Products From Supplier